Cranial Nerve Functions in Behçet's Disease and Their Relationship With Clinical Parameters
1 other identifier
observational
60
1 country
1
Brief Summary
The goal of this study is to find out whether cranial nerves are affected in people with Behçet's Disease (BD), and how this might relate to other disease features. Cranial nerves control important functions such as vision, facial movement, hearing, swallowing, and balance. The main questions this study will address are:
- Do people with BD have changes in cranial nerve function compared to healthy individuals?
- Are these changes linked to disease duration, symptoms, or lab results? Participants will:
- Answer questions about their medical history and BD symptoms
- Complete questionnaires on daily function, mood, and autonomic symptoms
- Have a clinical examination of all 12 cranial nerves
- Undergo non-invasive electrical tests to assess nerve function This study will not involve any medications. All procedures will be completed in one visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2025
CompletedFirst Posted
Study publicly available on registry
August 21, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedAugust 21, 2025
August 1, 2025
3 months
July 22, 2025
August 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Establish the presence or absence of cranial nerve involvement in BD.
Upon patient inclusion EMG and clinical examination is carried out
Once: Upon patient inclusion
Secondary Outcomes (1)
Investigate relation between disease duration (months) and cranial nerve involvement in BD patients
Once: Upon patient inclusion
Eligibility Criteria
Target Population: Patient Group: Diagnosed Behçet's patients aged 18-75 years Control Group: Age- and gender-matched healthy individuals without neurological, autoimmune, or inflammatory diseases Sample Size: Minimum 30 Behçet patients Minimum 30 healthy controls Recruitment: Participants will be recruited from Marmara University Pendik Research and Education Hospital. Healthy controls will be volunteers among hospital staff and relatives of patients.
You may qualify if:
- Aged 18-75
- Diagnosed with BD according to ACR/EULAR 2013 criteria (patient group)
- Healthy with no relevant medical history (control group)
You may not qualify if:
- Conditions affecting CN assessment (e.g., facial trauma, surgery, radiotherapy)
- Other rheumatologic or autoimmune diseases
- Psychiatric disorders, alcohol/substance abuse
- Pregnant women
- Use of pacemakers or recent botox to masseter muscle
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara Üniversitesi Tıp Fakültesi
Istanbul, Maltepe, 34854, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2025
First Posted
August 21, 2025
Study Start
October 1, 2025
Primary Completion
January 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
August 21, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share